EC Number |
Source Tissue |
Reference |
---|
1.14.14.14 | adrenal gland |
maternal ovaries and adrenals maintain high aromatase activity throughout gestation |
745021 |
1.14.14.14 | brain |
Cyp19a1b is solely detected at putative radial glial cells of the forebrain, close to the brain ventricles |
745054 |
1.14.14.14 | brain |
high transcript abundance in the female brain, followed by gonads, liver, gill, kidney and muscle |
745022 |
1.14.14.14 | brain |
high transcript abundance in the ovary and female brain, followed by the testis and male brain, and female liver and muscle |
745022 |
1.14.14.14 | brain |
higher aromatase expression in female compared with male cerebral vessels |
743990 |
1.14.14.14 | brain |
male brain aromatase activity is signficantly increased by treatments with estradiol or ethynylestradiol while female brain aromatase activity is unaffected |
744150 |
1.14.14.14 | C6 glioma cell |
cell line expresses aromatase mRNA and shows a cytoplasmic pattern of aromatase immunoreactivity. In addition, the cell line expresses estrogen receptor alpha |
726047 |
1.14.14.14 | cytotrophoblast |
villous cytotrophoblast cells |
764239 |
1.14.14.14 | embryo |
aromatase activity in the developing brains and gonads of embryos is comparable with measurements in oviparous reptiles. Aromatase activity in the embryonic gonads is low at embryonic stage 29-34, but increases significantly at mid-development and then remains high in late stage embryos |
745021 |
1.14.14.14 | glioma cell |
- |
726047 |